There’s been a lot of news about Alzheimer’s disease recently because of the annual meeting of the Alzheimer’s Association International Conference on Alzheimer’s Disease (AAICAD) which met from July 10 to 15, 2010 in Honolulu, Hawaii. The AAICAD is the world’s largest conference of its kind. It brought together almost 4,000 researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer’s disease and related disorders.

Alzheimer’s disease research continues to be under-funded, but this appears to be the most significant disease that the baby boomer generation will face. There were many interesting and significant items to come out of the conference, but I want to mention two of them because they immediately impact us. I mentioned in a previous post that participating in a clinical trial could prove to be very time-consuming, but if this is of interest to you, here is good news for you.

The Alzheimer’s Association announced the launch of Alzheimer’s Association TrialMatchTM, a confidential, free, and interactive tool that provides comprehensive clinical trial information and an individualized trial matching service for people with Alzheimer’s disease and related dementias. The Internet (www.alz.org/trialmatch) and phone-based (800-272-3900) program provides a first-of-its-kind service in Alzheimer’s by delivering individualized matches to clinical trials for people with Alzheimer’s, their healthcare professionals, caregivers, and healthy volunteers.

Second, we know that diet and exercise can play a role in either slowing down or reducing the risk of dementia. For example, adding turmeric to the diet (click here) might be beneficial.

Evidence from three long-term, large-scale studies (Framingham Study, Cardiovascular Health Study, NHANES III) supports the association of physical activity and certain dietary elements (tea, vitamin D) with possibly maintaining cognitive ability and reducing dementia risk in older adults. Plus, a new study in an animal model of Alzheimer’s reported today at AAICAD 2010 suggests that an antioxidant-rich diet with walnuts may benefit brain function. Research has pointed towards a number of factors that may impact our risk of Alzheimer’s and cognitive decline, the strongest being reducing cardiovascular risk factors. The Alzheimer’s Association and others have repeatedly called for longer-term, larger-scale research studies to clarify the roles that these factors play in the health of the aging brain. These studies from AAICAD 2010 are some of the first reports of this type in Alzheimer’s, and that is encouraging, but it is not yet definitive evidence.

Next year the group will meet in Paris, France from July 16-21. We look forward to more exciting news to come out of the meetings. For more research findings, click here.

ICAD 2011

Tagged with:

Filed under: Alzheimer's DiseaseAlzheimer's Disease ResearchClinical TrialsDementia

Like this post? Subscribe to my RSS feed and get loads more!